Hospital Pharmacy - February 2018 - 67

Wahking et al

18.

19.

20.

21.

22.

23.

24.

25.

26.
27.

28.

tion on two pulmonary medicine wards. Aliment Pharmacol
Ther. 2009;29(2):213-221.
Michal J, Henry T, Street C. Impact of a pharmacist-driven
protocol to decrease proton pump inhibitor use in nonintensive care hospitalized adults. Am J Health Syst Pharm.
2016;73(suppl 4):S126-S32.
Reimer C, Søndergaard B, Hilsted L, Bytzer P. Proton-pump
inhibitor therapy induces acid-related symptoms in healthy
volunteers after withdrawal of therapy. Gastroenterology.
2009;137(1):80-87.
Waldrum HL, Arnestad JS, Brenna E, Eide I, Syversen U,
Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut. 1996;39:649-653.
Reimer C, Bytzer P. Discontinuation of long-term proton pump
inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse. Eur J
Gastroenterol Hepatol. 2010;22(10):1182-1188.
Niklasson A, Lindström L, Simrén M, Lindberg G, Björnsson
E. Dyspeptic symptom development after discontinuation of a
proton pump inhibitor: a double-blind placebo-controlled trial.
Am J Gastroenterol. 2010;105(7):1531-1537.
Davis KW, Hanners RE, Lockwood SM. Implementation of a
proton pump inhibitor stewardship program. Am J Health Syst
Pharm. 2017;74(12):932-937.
Scarpignato C, Gatta L, Zullo Blandizzi C. Effective and safe
proton pump inhibitor therapy in acid-related diseases-a position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14:179.
Shaheen NJ, Falk GW, Iyer PG, Gerson L. ACG clinical guideline: diagnosis and management of Barrett's esophagus. Am J
Gastroenterol. 2016;111:30-50.
Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;107:345-360.
Abraham NS, Hlatky MA, Antman EM, et al. ACCF/ACG/AHA
2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID
use. Am J Gastroenterol. 2010;105:2533-2549.
Lanza FL, Chan FKL, Quigley EMM and the practice parameters committee of the American College of Gastroenterology.

29.

30.

31.

32.

33.

34.

35.

36.

37.

38.

Guidelines for the prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104:728-738.
Freedberg DE, Kim LS, Yang YX. The risks and benefits of
long-term use of proton pump inhibitors: expert review and
best practice advice from the American Gastroenterological
Association. Gastroenterology. 2017;152:706-715.
Ray WA, Chung CP, Murray KT, et al. Association of proton pump inhibitors with reduced risk of warfarin-related
serious upper gastrointestinal bleeding. Gastroenterology.
2016;151(6):1105-1112.
Pappas M, Jolly S, Vijan S. Defining appropriate use of protonpump inhibitors among medical patients. J Gen Intern Med.
2016;31:364-371.
Sachs G, Shin JM, Howden CW. Review article: the clinical
pharmacology of proton pump inhibitors. Aliment Pharmacol
Ther. 2006;23(2):2-8.
Limsrivilai J, Charatcharoenwitthaya P, Pausawasdi N,
Leelakusolvong S. Imipramine for treatment of esophageal
hypersensitivity and functional heartburn: a randomized
placebo-controlled trial. Am J Gastroenterol. 2016;111(2):
217-224.
Murie J, Allen J, Simmonds R, de Wet C. Glad you brought
it up: a patient-centered programme to reduce proton-pump
inhibitor prescribing in general medical practice. Qual Prim
Care. 2012;20(2):141-148.
Richy F, Bruyere O, Ethgen O, et al. Time dependent risk of
gastrointestinal complications induced by non-steroidal antiinflammatory drug use: a consensus statement using a metaanalytic approach. Ann Rheum Dis. 2004;63:759-766.
ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis.
ASHP Commission on Therapeutics and approved by the
ASHP Board of Directors on November 14, 1998. Am J Health
Syst Pharm. 1999;56(4):347-379.
Talley NJ, Herrick L, Locke GR. Antidepressants in functional dyspepsia. Expert Rev Gastroenterol Hepatol.
2010;4:5-8.
Ness-Jensen E, Lindam A, Lagergren J, Hveem K. Tobacco
smoking cessation and improved gastroesophageal reflux: a
prospective population-based cohort study: the HUNT study.
Am J Gastroenterol. 2014;109(2):171-177.

Table of Contents for the Digital Edition of Hospital Pharmacy - February 2018